An increasing proportion of patients achieve a low disease activity state or remission when switched from infliximab to abatacept regardless of initial infliximab treatment response: Results from the ATTEST trial

Category Primary study
JournalArthritis and Rheumatism
Year 2009
This article has no abstract
Epistemonikos ID: c9545c8300a9f2267b442136131e2f2700d8f52a
First added on: Feb 04, 2025